Factor V Deficient Plasma is manufactured from normal citrated human plasma that has been depleted of Factor V by selective affinity immuno-adsorption using antibodies directed towards FV.
Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and are available in 1ml vials to litre quantities. Our Factor V deficient plasma can be used for further manufacturing or research use only applications.
Product Code:FV-DP
Presentation: Frozen Factor V Deficient Plasma
Preparation/Handling: Thaw 1 ml vials in 37oC water bath for 5 minutes; for bulk volumes, thawing time will be dependent on bottle size.
Storage and Stability: Plasma is shipped frozen and should be stored below -60oC. Product is stable until date stated on vial label when stored at -60oC. Once thawed, plasma is stable for 4 hours at 2-8oC in original vial.
Factor V (formerly referred to as accelerator globulin and labile factor) is a large glycoprotein (320 kDa) that is produced in the liver. The gene that encodes factor V (FV) is located on chromosome 1. A congenital deficiency of FV is a hemorrhagic disorder inherited as an autosomal recessive disease. The concentration of FV in plasma is typically 10 μg/mL. FV is a pro-cofactor that is activated through limited proteolysis by thrombin, or by activated factor X in the presence of phospholipid surface. Other physiologic activators of FV include plasmin, neutrophil elastase and platelet calpain. The activated cofactor (FVa) is an essential component of the prothrombin activator complex, which consists of FVa, activated factor X, calcium and anionic phospholipid surface. The intact prothrombinase complex activates prothrombin to thrombin at a rate 300,000-fold greater than activated factor X alone. In a positive feedback loop, the thrombin generated accelerates its own generation by activating more FV to FVa. Thrombin also acts to down-regulate FVa indirectly by activating Protein C, which inactivates FVa cofactor activity1-3.
References and Reviews
Kane WH, Davie EW; Blood Coagulation Factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71:539, 1988.
Hoyer, LW, Wyshock EG, Colman RW, in Hemostasis and Thrombosis, 3rd Edition, eds. RW Colman, J Hirsh, VJ Marder and EW Salzman, pp. 109-133, J.B. Lippincott Co., Philadelphia, 1994.
Nesheim ME, Katzmann JA, Tracy PB, Mann KG; in Methods in Enzymology 80:249, 1980.
Factor V Deficient Plasma
FV-DP – Factor V Deficient Plasma – 1ml or bulk quantities
Description
Factor V Deficient Plasma
Factor V Deficient Plasma is manufactured from normal citrated human plasma that has been depleted of Factor V by selective affinity immuno-adsorption using antibodies directed towards FV.
Only the highest quality citrated plasma is used as starting material and in many cases the parent plasma is available as control material. Plasma products are typically buffered with the addition of HEPES to 20mM final concentration and are available in 1ml vials to litre quantities. Our Factor V deficient plasma can be used for further manufacturing or research use only applications.
Product Code: FV-DP
Presentation: Frozen Factor V Deficient Plasma
Preparation/Handling: Thaw 1 ml vials in 37oC water bath for 5 minutes; for bulk volumes, thawing time will be dependent on bottle size.
Storage and Stability: Plasma is shipped frozen and should be stored below -60oC. Product is stable until date stated on vial label when stored at -60oC. Once thawed, plasma is stable for 4 hours at 2-8oC in original vial.
Certificate of Analysis: available upon request
Description of Factor V
Factor V (formerly referred to as accelerator globulin and labile factor) is a large glycoprotein (320 kDa) that is produced in the liver. The gene that encodes factor V (FV) is located on chromosome 1. A congenital deficiency of FV is a hemorrhagic disorder inherited as an autosomal recessive disease. The concentration of FV in plasma is typically 10 μg/mL. FV is a pro-cofactor that is activated through limited proteolysis by thrombin, or by activated factor X in the presence of phospholipid surface. Other physiologic activators of FV include plasmin, neutrophil elastase and platelet calpain. The activated cofactor (FVa) is an essential component of the prothrombin activator complex, which consists of FVa, activated factor X, calcium and anionic phospholipid surface. The intact prothrombinase complex activates prothrombin to thrombin at a rate 300,000-fold greater than activated factor X alone. In a positive feedback loop, the thrombin generated accelerates its own generation by activating more FV to FVa. Thrombin also acts to down-regulate FVa indirectly by activating Protein C, which inactivates FVa cofactor activity1-3.
References and Reviews
Related Products:
Factor V Polyclonal Antibody – HRP Conjugated
SAFV-HRP – Sheep anti human Factor V, peroxidase conjugated IgG (0.2 mg vial)
Factor V Paired Antibody Set
FV-EIA – Factor V Paired Antibody Set – 5 plate set
Frozen Factor V Deficient Plasma
FRDP050105 – VisuDep-F Frozen Factor V deficient plasma – 5 x 1ml Box (IVD)
FRDP050125 – VisuDep-F Frozen Factor V deficient plasma – 25 x 1ml Box (IVD)
Factor V Deficient Plasma
FV-DP – Factor V Deficient Plasma – 1ml or bulk quantities
Factor V Polyclonal Antibody – Affinity Purified
SAFV-AP – Sheep anti human Factor V, affinity purified IgG (0.5 mg vial)
Factor V Polyclonal Antibody – Affinity Purified – Biotinylated
SAFV-APBIO – Sheep anti human Factor V, affinity purified, Biotinylated IgG (0.1 mg vial)
Factor V Polyclonal Antibody
SAFV-IG – Sheep anti human Factor V, purified IgG (10mg vial)
Factor V Inhibitor Plasma
INH5-DP – Frozen Factor V Inhibitor Plasma – 1ml and bulk
INH5-LDP – Lyophilized Factor V Inhibitor Plasma – 1ml
Factor V Polyclonal Antibody – Affinity Purified – FITC Conjugated
SAFV-APFTC – Sheep anti human Factor V, affinity purified, FITC conjugated IgG (0.1 mg vial)